“GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE”. International Journal of Medical Sciences, vol. 6, no. 4, Apr. 2026, pp. 849-55, https://doi.org/10.55640/.